Cannabidiol Alters Mitochondrial Bioenergetics via VDAC1 and Triggers Cell Death in Hormone-Refractory Prostate Cancer

Investigators demonstrated that two multi-target natural products, cannabidiol and cannabigerol, suppressed hormone refractory prostate cancer development in the Transgenic Adenocarcinoma of the Mouse Prostate model by reprogramming metabolic and oncogenic signaling.